FR2485372B1 - PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ACUTE ALCOHOLIC POISONING BASED ON PYRIDOXIN 5-OXO-2-PYRROLIDONE CARBOXYLATE AND PROCESS FOR PREPARING THE SAME - Google Patents

PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ACUTE ALCOHOLIC POISONING BASED ON PYRIDOXIN 5-OXO-2-PYRROLIDONE CARBOXYLATE AND PROCESS FOR PREPARING THE SAME

Info

Publication number
FR2485372B1
FR2485372B1 FR8111006A FR8111006A FR2485372B1 FR 2485372 B1 FR2485372 B1 FR 2485372B1 FR 8111006 A FR8111006 A FR 8111006A FR 8111006 A FR8111006 A FR 8111006A FR 2485372 B1 FR2485372 B1 FR 2485372B1
Authority
FR
France
Prior art keywords
pyridoxin
oxo
preparing
treatment
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8111006A
Other languages
French (fr)
Other versions
FR2485372A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratori Baldacci SpA
Original Assignee
Laboratori Baldacci SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT23103/80A external-priority patent/IT1131856B/en
Priority claimed from IT23102/80A external-priority patent/IT1131855B/en
Application filed by Laboratori Baldacci SpA filed Critical Laboratori Baldacci SpA
Publication of FR2485372A1 publication Critical patent/FR2485372A1/en
Application granted granted Critical
Publication of FR2485372B1 publication Critical patent/FR2485372B1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C07D213/66—One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
    • C07D213/67—2-Methyl-3-hydroxy-4,5-bis(hydroxy-methyl)pyridine, i.e. pyridoxine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C07D213/20—Quaternary compounds thereof
FR8111006A 1980-06-30 1981-06-03 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ACUTE ALCOHOLIC POISONING BASED ON PYRIDOXIN 5-OXO-2-PYRROLIDONE CARBOXYLATE AND PROCESS FOR PREPARING THE SAME Expired FR2485372B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT23103/80A IT1131856B (en) 1980-06-30 1980-06-30 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALCOHOLIC INTOXICATIONS
IT23102/80A IT1131855B (en) 1980-06-30 1980-06-30 PROCEDURE FOR THE PREPARATION OF PYROLIDON PYRIDEXIN CARBOXYLATE

Publications (2)

Publication Number Publication Date
FR2485372A1 FR2485372A1 (en) 1981-12-31
FR2485372B1 true FR2485372B1 (en) 1985-08-09

Family

ID=26328336

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8111006A Expired FR2485372B1 (en) 1980-06-30 1981-06-03 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ACUTE ALCOHOLIC POISONING BASED ON PYRIDOXIN 5-OXO-2-PYRROLIDONE CARBOXYLATE AND PROCESS FOR PREPARING THE SAME

Country Status (3)

Country Link
AU (1) AU544780B2 (en)
FR (1) FR2485372B1 (en)
PT (1) PT73287B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1263957B (en) * 1993-02-23 1996-09-05 THERAPEUTIC USE OF PYROLIDON CARBOXYLATE OF PYRIDOXY
IT1263956B (en) * 1993-02-23 1996-09-05 PROCEDURE FOR THE PREPARATION OF 5-OXO-2-PYROLIDONCARBOSSILATE OF PYRIDOXY

Also Published As

Publication number Publication date
AU7234981A (en) 1982-01-07
PT73287A (en) 1981-07-01
AU544780B2 (en) 1985-06-13
FR2485372A1 (en) 1981-12-31
PT73287B (en) 1982-07-22

Similar Documents

Publication Publication Date Title
BE890574A (en) AMINOALCOYL-FURANNE DERIVATIVE, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
FR2569402B1 (en) 3,5-PYRIDINE-DICARBOXYLIC ACID DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
FR2568472B1 (en) DELAYED PHARMACEUTICAL PREPARATIONS AND PROCESS FOR MAKING SAME
BE881217A (en) PROCESS FOR PREPARING INTERFERON TYPE II AND PREPARATIONS CONTAINING INTERFERON TYPE II
FR2505835B1 (en) NOVEL 1,2-DIAMINOCYCLOBUTENE-3,4-DIONES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
FR2555584B1 (en) FLUORO-6-DIHYDRO-1,4-OXO-4-PIPERAZINYL SUBSTITUE-7-QUINOLINE-CARBOXYLIC-3 ACID DERIVATIVES AND PROCESS FOR THEIR PREPARATION AND ANTI-BACTERIAL-BASED PHARMACEUTICAL COMPOSITIONS
OA09014A (en) New cepheme and process for its preparation.
FR2533439B1 (en) NOVEL PHARMACEUTICAL COMPOSITIONS BASED ON CIS-PLATIN-II-DIAMMINO-DICHLORIDE AND PROCESS FOR PREPARING THEM
FR2495154B1 (en) 5'-AMINOALKYL-4 ', 4, 8-TRIALKYLPSORALENES, THEIR PRODUCTION PROCESS AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
FR2490493B1 (en) PHARMACEUTICAL OR FOOD COMPOSITION CONTAINING PYRIDOXIN A -CETOGLUTARATE, PROCESS FOR ITS PREPARATION
BE858883A (en) PRODUCT FOR CLARIFYING SERUMS AND PROCESS FOR ITS PREPARATION
FR2510572B1 (en) NOVEL THIAZOLIDINEDIONES, THEIR PRODUCTION PROCESS AND PHARMACEUTICAL PREPARATION CONTAINING THEM
FR2569702B1 (en) NOVEL 4'-DESCHLOROREBECCAMYCINE, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AND PROCESS FOR THE PREPARATION THEREOF
FR2618445B1 (en) EMULSION PAINT AND PROCESS FOR ITS PREPARATION
FR2508487B1 (en) ASSAY PROCESS FOR LIPID-LIKE COMPONENT, ASSAY COMPOSITION, AND PROCESS FOR PRODUCING ENZYME USED THEREFOR
FR2496106B1 (en) 7-ACYLAMINOCEPHALOSPORANIC ACID DERIVATIVES AND PROCESS FOR THEIR PREPARATION
BE889604A (en) PROCESS FOR THE PREPARATION OF ACETALDEHYDE AND ETHANOL
FR2485372B1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ACUTE ALCOHOLIC POISONING BASED ON PYRIDOXIN 5-OXO-2-PYRROLIDONE CARBOXYLATE AND PROCESS FOR PREPARING THE SAME
FR2529081B1 (en) THERAPEUTIC COMPOSITION BASED ON 5-HYDROXYDECANOIC ACID OR A DERIVATIVE THEREOF FOR THE TREATMENT OF CARDIOVASCULAR DISEASES
FR2565105B1 (en) STABLE PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF KETOSIS AND METHOD FOR PREPARING THE SAME
BE873515A (en) METHOD AND DEVICE FOR THE TREATMENT OF SMOKING ARTICLES
FR2528422B1 (en) NOVEL 1,2,3,4-TETRAHYDRONAPHTALENE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THESE DERIVATIVES
FR2315910A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING HETEROCOLLOIDAL "DEBRYCIN" AND PROCESS FOR THEIR PREPARATION
BE894228A (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ATHEROSCLEROSIS
FR2299120A1 (en) PROCESS AND MACHINE FOR SURFACE TREATMENT OF AI-SHAPED PARTS